Point-of-care monitoring of anticoagulant therapy in paediatric patients

Progress in Pediatric Cardiology

Volumn 21, Issue 1, 2005, Pages 53-61

  Newall, Fiona ^a   Bauman, Mary E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anticoagulation; Congenital heart disease; Low molecular weight heparin; Paediatric; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7A; DALTEPARIN; ENOXAPARIN; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN; TINZAPARIN; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; BONE DENSITY; CLINICAL TRIAL; CONGENITAL HEART DISEASE; DOSE RESPONSE; DRUG MONITORING; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER DYSFUNCTION; MOLECULAR WEIGHT; NONHUMAN; OSTEOPOROSIS; PATIENT EDUCATION; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; REVIEW; TERATOGENESIS; TERATOGENICITY; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 28844508677     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2005.09.007     Document Type: Article

References (42)

1. F. Newall, H. Savoia, J. Campbell, and P. Monagle Anticoagulation clinics for children achieve improved warfarin management Thromb Res 114 1 2004 5 9
2. J.D. Horton, and B.M. Bushwick Warfarin therapy: evolving strategies in anticoagulation Am Fam Physician 59 3 1999 635 646
3. J. Hirsh, J. Dalen, and D.R. Anderson Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 119 1 Suppl 2001 8S 21S
4. T. Gibbar-Clements, D. Shirrell, R. Dooley, and B. Smiley The challenge of warfarin therapy Am J Nurs 100 3 2000 38 40
5. J. Hirsh, and S.M. Bates Clinical trials that have influenced the treatment of venous thromboembolism: a historical perspective Ann Intern Med 134 5 2001 409 417
6. C. Keller, A.C. Matzdorff, and B. Kemkes-Matthes Pharmacology of warfarin and clinical implications Semin Thromb Hemost 25 1 1999 13 16
7. M. Andrew, V. Marzinotto, and L.A. Brooker Oral anticoagulation therapy in pediatric patients: a prospective study Thromb Haemost 71 3 1994 265 269
8. D.J. Clark Venous thromboembolism in paediatric practice Paediatr Anaesth 9 6 1999 475 484
9. H. Desai, and E. Farrington Anticoagulation with warfarin in pediatrics Pediatr Nurs 26 2 2000 199 203
10. A.D. Michelson, E. Bovill, and M. Andrew Antithrombotic therapy in children Chest 108 4 1995 506S 522S
11. P. Monagle, A.D. Michelson, E. Bovill, and M. Andrew Antithrombotic therapy in children Chest 119 1 Suppl 2001 344S 370S
12. W. Streif, M. Andrew, and V. Marzinotto Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients Blood 94 9 1999 3007 3014
13. V. Marzinotto, P. Monagle, and A. Chan Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting Pediatr Cardiol 21 4 2000 347 352
14. P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. Michelson Antithrombotic therapy in children Chest 126 2004 645S 687S
15. A.S. Gallus, R.I. Baker, B.H. Chong, P.A. Ockelford, and A.M. Street Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis Med J Aust 172 12 2000 600 605
16. P. Massicotte, V. Marzinotto, P. Vegh, M. Adams, and M. Andrew Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor J Pediatr 127 3 1995 389 394
17. J. Ansell, J. Hirsh, and J. Dalen Managing oral anticoagulant therapy Chest 119 2001 22S 38S
18. Newall F, Bauman M. Point-of-care antithrombotic monitoring in children. Thromb Res in press.
19. J.E. Ansell, A. Hamke, A. Holden, and N. Knapic Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times Am J Clin Pathol 91 1989 587 589
20. J. Ansell, A. Holden, and N. Knapic Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times Arch Intern Med 149 11 1989 2509 2511
21. I. Jennings, R.J. Luddington, and T. Baglin Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation J Clin Pathol 44 11 1991 950 953
22. M.J. Kemme, R.A. Faaij, and R.C. Schoemaker Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants Blood Coagul Fibrinolysis 12 7 2001 583 591
23. S. Kitchen, and F.E. Preston Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins J Clin Pathol 50 11 1997 951 956
24. D.M. Lutomski Warfarin, short bowel syndrome, and intravenous lipids Pharmacotherapy 18 6 1998 1375 1376
25. V. Ignjatovic, C. Barnes, F. Newall, S. Hamilton, J. Burgess, and P. Monagle Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio Thromb Haemost 92 4 2004 734 737
26. W.L. Nowatzke, M. Landt, C. Smith, T. Wilhite, C. Canter, and L. Luchtman-Jones Whole blood international normalization ratio measurements in children using near-patient monitors J Pediatr Hematol Oncol 25 1 2003 33 37
27. T.D. Christensen, J. Attermann, V.E. Hjortdal, M. Maegaard, and J.M. Hasenkam Self-management of oral anticoagulation in children with congenital heart disease Cardiol Young 11 3 2001 269 276
28. T.D. Christensen, N.T. Andersen, J. Attermann, V.E. Hjortdal, M. Maegaard, and J.M. Hasenkam Mechanical heart valve patients can manage oral anticoagulant therapy themselves Eur J Cardiothorac Surg 23 3 2003 292 298
29. M. Andrew, J. Ansell, D. Becker, R. Becker, and A. Triplett Multi-center trial of accurate home self testing in oral anticoagulant patients with a novel whole blood system Blood 88 1996 179a [suppl]
30. F. Newall, H. Savoia, and J. Campbell Incidence of major bleeding in a large paediatric cohort of patients requiring warfarin therapy J Thromb Haemost 3 Supplement 1 2005 (Aug)
31. P. Massicotte, J. Julian, and C. Webber Osteoporosis: a potential complication of long term warfarin therapy Thromb Haemost 1999 1333a [Abstract, Suppl]
32. M. Monreal, A. Olive, E. Lafoz, and L. del Rio Heparins, coumarin, and bone density Lancet 338 8768 1991 706
33. H.N. Rosen, L.A. Maitland, J.W. Suttie, W.J. Manning, R.J. Glynn, and S.L. Greenspan Vitamin K and maintenance of skeletal integrity in adults Am J Med 94 1 1993 62 68
34. J.S. Ginsberg, I. Greer, and J. Hirsh Use of antithrombotic agents during pregnancy Chest 119 1 Suppl 2001 122S 131S
35. M.R. Toglia, and J.G. Weg Venous thromboembolism during pregnancy N Engl J Med 335 2 1996 108 114
36. J. Hirsh, and R. Raschke Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 2004 188S 203S
37. D. Dix, M. Andrew, and V. Marzinotto The use of low molecular weight heparin in pediatric patients: a prospective cohort study J Pediatr 136 4 2000 439 445
38. C.J. van Dongen, A.G. van den Belt, M.H. Prins, and A.W. Lensing Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism Cochrane Database Syst Rev 4 2004 [CD001100]
39. P. Massicotte, M. Adams, V. Marzinotto, L.A. Brooker, and M. Andrew Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study J Pediatr 128 3 1996 313 318
40. M.P. Massicotte, J.A. Julian, M. Gent The PROTEKT Study Group An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line related thrombotic complications in children: the PROTEKT trial Thromb Res 109 2003 101 108
41. S. Massonet-Castel, E. Pelissier, and L. Bara Partial reversal of low molecular weight heparin (PK 10169) anti Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation Haemostasis 16 1986 139
42. M. Andrew, M. David, and M. Adams Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE Blood 83 5 1994 1251 1257